Course Exam
301907 VO Development of novel cancer immunotherapies (2019W)
from target identification through target validation to clinical trials
Labels
WHEN?
Sunday
01.03.2020
Examiners
Information
Assessment and permitted materials
written exam
Minimum requirements and assessment criteria
100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)
Last modified: We 19.08.2020 07:49